Report Detail
Global (United States, European Union and China) Bladder Cancer Market Research Report 2019-2025
- RnM3685548 |
- 20 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Other
Bladder cancer is known to be a urologic malignancy that occurs in the tissues of the urinary bladder. It is generally characterized by the uncontrolled division of cells arising from the epithelial lining and may proliferate to the muscular wall of the urinary bladder. The exact causes of bladder cancer are still unknown.
In 2019, the market size of Bladder Cancer is 460 million US$ and it will reach 1140 million US$ in 2025, growing at a CAGR of 12.1% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bladder Cancer.
This report studies the global market size of Bladder Cancer, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Bladder Cancer production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bristol-Myers Squibb
Eli Lilly
F. Hoffman-La Roche
Pfizer
Accord Healthcare
AstraZeneca
Bedford Lab
Merck
Sanofi
Market Segment by Product Type
Intravesical therapy
Chemotherapy
Preservation therapy
Market Segment by Application
Hospital
Clinic
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Bladder Cancer status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Bladder Cancer manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Bladder Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Bladder Cancer Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Intravesical therapy
- 1.3.3 Chemotherapy
- 1.3.4 Preservation therapy
- 1.4 Market Segment by Application
- 1.4.1 Global Bladder Cancer Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Bladder Cancer Production Value 2014-2025
- 2.1.2 Global Bladder Cancer Production 2014-2025
- 2.1.3 Global Bladder Cancer Capacity 2014-2025
- 2.1.4 Global Bladder Cancer Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Bladder Cancer Market Size CAGR of Key Regions
- 2.2.2 Global Bladder Cancer Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Bladder Cancer Capacity by Manufacturers
- 3.1.2 Global Bladder Cancer Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Bladder Cancer Revenue by Manufacturers (2014-2019)
- 3.2.2 Bladder Cancer Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Bladder Cancer Market Concentration Ratio (CR5 and HHI)
- 3.3 Bladder Cancer Price by Manufacturers
- 3.4 Key Manufacturers Bladder Cancer Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Bladder Cancer Market
- 3.6 Key Manufacturers Bladder Cancer Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Intravesical therapy Production and Production Value (2014-2019)
- 4.1.2 Chemotherapy Production and Production Value (2014-2019)
- 4.1.3 Preservation therapy Production and Production Value (2014-2019)
- 4.2 Global Bladder Cancer Production Market Share by Type
- 4.3 Global Bladder Cancer Production Value Market Share by Type
- 4.4 Bladder Cancer Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Bladder Cancer Consumption by Application
6 Production by Regions
- 6.1 Global Bladder Cancer Production (History Data) by Regions 2014-2019
- 6.2 Global Bladder Cancer Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Bladder Cancer Production Growth Rate 2014-2019
- 6.3.2 United States Bladder Cancer Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Bladder Cancer Import & Export
- 6.4 European Union
- 6.4.1 European Union Bladder Cancer Production Growth Rate 2014-2019
- 6.4.2 European Union Bladder Cancer Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Bladder Cancer Import & Export
- 6.5 China
- 6.5.1 China Bladder Cancer Production Growth Rate 2014-2019
- 6.5.2 China Bladder Cancer Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Bladder Cancer Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Bladder Cancer Consumption by Regions
- 7.1 Global Bladder Cancer Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Bladder Cancer Consumption by Type
- 7.2.2 United States Bladder Cancer Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Bladder Cancer Consumption by Type
- 7.3.2 European Union Bladder Cancer Consumption by Application
- 7.4 China
- 7.4.1 China Bladder Cancer Consumption by Type
- 7.4.2 China Bladder Cancer Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Bladder Cancer Consumption by Type
- 7.5.2 Rest of World Bladder Cancer Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Bristol-Myers Squibb
- 8.1.1 Bristol-Myers Squibb Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Bladder Cancer
- 8.1.4 Bladder Cancer Product Introduction
- 8.1.5 Bristol-Myers Squibb Recent Development
- 8.2 Eli Lilly
- 8.2.1 Eli Lilly Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Bladder Cancer
- 8.2.4 Bladder Cancer Product Introduction
- 8.2.5 Eli Lilly Recent Development
- 8.3 F. Hoffman-La Roche
- 8.3.1 F. Hoffman-La Roche Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Bladder Cancer
- 8.3.4 Bladder Cancer Product Introduction
- 8.3.5 F. Hoffman-La Roche Recent Development
- 8.4 Pfizer
- 8.4.1 Pfizer Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Bladder Cancer
- 8.4.4 Bladder Cancer Product Introduction
- 8.4.5 Pfizer Recent Development
- 8.5 Accord Healthcare
- 8.5.1 Accord Healthcare Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Bladder Cancer
- 8.5.4 Bladder Cancer Product Introduction
- 8.5.5 Accord Healthcare Recent Development
- 8.6 AstraZeneca
- 8.6.1 AstraZeneca Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Bladder Cancer
- 8.6.4 Bladder Cancer Product Introduction
- 8.6.5 AstraZeneca Recent Development
- 8.7 Bedford Lab
- 8.7.1 Bedford Lab Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Bladder Cancer
- 8.7.4 Bladder Cancer Product Introduction
- 8.7.5 Bedford Lab Recent Development
- 8.8 Merck
- 8.8.1 Merck Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Bladder Cancer
- 8.8.4 Bladder Cancer Product Introduction
- 8.8.5 Merck Recent Development
- 8.9 Sanofi
- 8.9.1 Sanofi Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Bladder Cancer
- 8.9.4 Bladder Cancer Product Introduction
- 8.9.5 Sanofi Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Bladder Cancer Capacity, Production Forecast 2019-2025
- 9.1.2 Global Bladder Cancer Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Bladder Cancer Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Bladder Cancer Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Bladder Cancer Production Forecast by Type
- 9.7.2 Global Bladder Cancer Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Bladder Cancer Sales Channels
- 10.2.2 Bladder Cancer Distributors
- 10.3 Bladder Cancer Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Bladder Cancer. Industry analysis & Market Report on Bladder Cancer is a syndicated market report, published as Global (United States, European Union and China) Bladder Cancer Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Bladder Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
